Clinical Features, Treatment and Outcomes of Dogs With Psoriasiform Lichenoid Dermatosis Associated With Calcineurin Inhibitor Therapy
Veterinary Dermatology · 2026-02 · 37 (1) · 51-64
DOI: 10.1111/vde.70014 ↗Kurz gefasst
Fachartikel in der Zeitschrift Veterinary Dermatology, online erschienen am 21.09.2025. Verfasst von E R Davis und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Studies and Advanced Medicine, University of Pennsylvania, School of Veterinary Medicine, Philadelphia, Pennsylvania, USA. Hauptthemen laut MEDLINE: Dog Diseases, Calcineurin Inhibitors, Lichenoid Eruptions, Psoriasis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben.
Abstract (Originalsprache)
Background
Psoriasiform lichenoid dermatosis (PLD) is a rare lesion in dogs receiving calcineurin inhibitors, associated with staphylococcal infection.
Objectives
To define the clinical features of dogs with a histopathologic diagnosis of PLD.
Results
Twenty‐eight dogs were included in this retrospective study. PLD was focal (4/28), multifocal (17/28) or regional/generalised (7/28). Twenty‐seven of 28 dogs received a calcineurin inhibitor with a median time to lesion onset of 6 months (1–24 months). Twenty‐three of 28 dogs received ciclosporin (ciclosporin alone: 15/23; ciclosporin with ketoconazole: 7/23). Formulations included generic modified ciclosporin (12/23), brand‐name modified ciclosporin (7/23), compounded modified ciclosporin (1/23) or unknown formulation (3/22). Four dogs had gingival hyperplasia or paw‐pad hyperkeratosis. Four dogs received topical tacrolimus. No breed or sex predilection was found. The median age of onset was 7 years (3–12 years). In 22/28 dogs, bacteria were seen on lesional cytology, and Staphylococcus pseudintermedius was isolated with bacterial culture from nine dogs. Short‐read whole genome sequencing was performed on three isolates. Most dogs received antimicrobials before (14/28) and/or after diagnosis (22/28 dogs). Outcomes/Clinical Relevance PLD occurs in adult dogs irrespective of breed with varied forms of calcineurin inhibitors. Twenty of 28 dogs achieved > 50% improvement or complete (100%) lesion resolution after topical and/or systemic antimicrobial therapy and discontinuation with or without dose reduction of the calcineurin inhibitor.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Studies and Advanced Medicine, University of Pennsylvania, School of Veterinary Medicine, Philadelphia, Pennsylvania, USA.
- Department of Pathobiology, University of Pennsylvania, School of Veterinary Medicine, Philadelphia, Pennsylvania, USA.
ORCID-Profile: E R Davis
Zitieren
APA
Davis, E. R., Mauldin, E. A., Cain, C. L., Cole, S., & Bradley, C. W. (2026). Clinical Features, Treatment and Outcomes of Dogs With Psoriasiform Lichenoid Dermatosis Associated With Calcineurin Inhibitor Therapy. Veterinary Dermatology, 37(1), 51-64. https://doi.org/10.1111/vde.70014
Vancouver
Davis ER, Mauldin EA, Cain CL, Cole S, Bradley CW. Clinical Features, Treatment and Outcomes of Dogs With Psoriasiform Lichenoid Dermatosis Associated With Calcineurin Inhibitor Therapy. Veterinary Dermatology. 2026;37(1):51-64. doi:10.1111/vde.70014
BibTeX
@article{Davis2026,
author = {Davis, E R and Mauldin, E A and Cain, C L and Cole, S and Bradley, C W},
title = {Clinical Features, Treatment and Outcomes of Dogs With Psoriasiform Lichenoid Dermatosis Associated With Calcineurin Inhibitor Therapy},
journal = {Veterinary Dermatology},
year = {2026},
volume = {37},
number = {1},
pages = {51--64},
doi = {10.1111/vde.70014}
}
EUVIMED